tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alexandria Hammond, 8 are a SELL (57.14%), 2 are a HOLD (14.29%), 4 are a BUY (28.57%).
Analyst Alexandria Hammond, currently employed at WOLFE, carries an average stock price target met ratio of 93.33% that have a potential upside of 19.72% achieved within 88 days. Previously, Alexandria Hammond worked at BAML.
Alexandria Hammond’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRNA, Moderna at 25-Aug-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/15/2024. The price target of $40 was fulfilled within 7 days with a profit of $3.15 (8.55%) receiving and performance score of 12.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$175
$31.28 (21.76%)
$155
Hold Since 04-Sep-2024
$123
$-20.72 (-14.42%)
$120
1 months 7 days ago
(05-Aug-2026)
75/92 (81.52%)
$-8.76 (-6.65%)
1717
Buy Since 06-Oct-2025
$170
$26.28 (18.29%)
$170
1 months 7 days ago
(05-Aug-2026)
4/7 (57.14%)
$38.24 (29.02%)
113
Buy Since 22-Apr-2025
$155
$11.28 (7.85%)
$155
1 months 7 days ago
(05-Aug-2026)
21/26 (80.77%)
$23.24 (17.64%)
352
Buy Since 12-Feb-2025
$165
$21.28 (14.81%)
$166
1 months 16 days ago
(27-Jul-2026)
41/44 (93.18%)
$34.48 (26.42%)
557
Which stock is Alexandria Hammond most bullish on?
Which stock is Alexandria Hammond most reserved on?
What Year was the first public recommendation made by Alexandria Hammond?
